Diagnosed with type II diabetes more than 20 years ago, Angie Lachocki has tried to focus on her health. In October 2022, she visited her family doctor for a routine annual check up. Her doctor did some bloodwork and noted that her A1C levels were creeping up, so she...
Dr. Eugene Koay, Associate Professor in the Department of Gastrointestinal Radiation Oncology at The University of Texas MD Anderson Cancer Center, is the lead researcher on an innovative study funded by Pancreatic Cancer Canada that is harnessing artificial...
Spotlight: Dr. Shiva Jayaraman on NeoPancONE and building a first-class pancreatic cancer care program at St. Joseph’s Health Centre By Ali Schofield As hospitals across the country regain capacity amid the Covid-19 pandemic, more NeoPancONE participating trial...
Today I am thrilled to announce the launch of our next landmark research investment, PASS-01: a clinical trial that will finally address the diverse nature of this disease and provide personalized treatment options for advanced pancreatic cancer patients....
For several months the COVID-19 crisis has caused many research projects to slow, but Pancreatic Cancer Canada’s research program has not been idle. We have taken this time to quietly prepare for our next big project, because even in the midst of...
Pancreatic Cancer Clinical Trial Launches During Pandemic With Aim to Change Standard of Care for Patients TORONTO, ON, July 15, 2020 – Pancreatic Cancer Canada announced today the launch of NeoPancONE, a Phase II clinical trial that aims to be a curative strategy for...
Recent Comments